CAC
JNCE

Cowen and Company’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Cowen and Company’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,647,430
Closed -$4.05M – 696
2022
Q4 		$4.05M Hold
3,647,430
– – 0.42% 36
2022
Q3 		$8.54M Buy
3,647,430
+804,281
+28% +$1.88M 0.82% 29
2022
Q2 		$8.62M Buy
2,843,149
+2,268,814
+395% +$6.87M 0.83% 29
2022
Q1 		$3.9M Buy
+574,335
New +$3.9M 0.38% 43